The Controversial History of Hormone Replacement Therapy

被引:129
|
作者
Cagnacci, Angelo [1 ]
Venier, Martina [1 ]
机构
[1] Azienda Sanit Univ Integrata, Obstet & Gynecol Unit, I-33100 Udine, Italy
来源
MEDICINA-LITHUANIA | 2019年 / 55卷 / 09期
关键词
hormone replacement therapy; osteoporosis; breast cancer; cardiovascular disease; BREAST-CANCER INCIDENCE; CORONARY-HEART-DISEASE; ESTROGEN PLUS PROGESTIN; POSTMENOPAUSAL WOMEN; ENDOMETRIAL CANCER; MEDROXYPROGESTERONE ACETATE; CARDIOVASCULAR-DISEASE; ENDOTHELIAL FUNCTION; FRACTURE INCIDENCE; RANDOMIZED-TRIAL;
D O I
10.3390/medicina55090602
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The history of hormone replacement therapy (HRT) started in the 1960s, with very high popularity in the 1990s. The first clinical trials on HRT and chronic postmenopausal conditions were started in the USA in the late 1990s. After the announcement of the first results of the Women's Health Initiative (WHI) in 2002, which showed that HRT had more detrimental than beneficial effects, HRT use dropped. The negative results of the study received wide publicity, creating panic among some users and new guidance for doctors on prescribing HRT. The clear message from the media was that HRT had more risks than benefits for all women. In the following years, a reanalysis of the WHI trial was performed, and new studies showed that the use of HRT in younger women or in early postmenopausal women had a beneficial effect on the cardiovascular system, reducing coronary disease and all-cause mortality. Notwithstanding this, the public opinion on HRT has not changed yet, leading to important negative consequences for women's health and quality of life.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Menopause hormone replacement therapy:: controversial, accuracy and outlook issues
    Pérez-López, FR
    MEDICINA CLINICA, 2003, 120 (04): : 148 - 155
  • [2] Hormone replacement therapy: consensus and controversies
    Shoupe, D.
    PANMINERVA MEDICA, 2014, 56 (04) : 263 - 272
  • [3] Coronary heart disease and hormone replacement therapy after the menopause
    Hodis, H. N.
    Mack, W. J.
    CLIMACTERIC, 2009, 12 : 71 - 75
  • [4] Hormone replacement therapy in women with systemic lupus erythematosus and risk of cardiovascular disease
    Hochman, J.
    Urowitz, M. B.
    Ibanez, D.
    Gladman, D. D.
    LUPUS, 2009, 18 (04) : 313 - 317
  • [5] The effects of estrogen and hormone replacement therapy on cardiovascular systems
    Hashemzadeh, Mehrnoosh
    Romo, Ryan
    Arreguin, Joseph M.
    Movahed, Mohammed Reza
    FUTURE CARDIOLOGY, 2020, 17 (02) : 347 - 353
  • [6] Prothrombotic mutations, family history and the risk of thrombosis in postmenopausal women: implications for hormone replacement therapy
    Botto, N.
    Maffei, S.
    Manfredi, S.
    Colombo, M. G.
    Mazzone, A. M.
    Andreassi, M. G.
    CLIMACTERIC, 2011, 14 (01) : 25 - 30
  • [7] Hormone replacement therapy and prevention of chronic conditions
    Gambacciani, M.
    Cagnacci, A.
    Lello, S.
    CLIMACTERIC, 2019, 22 (03) : 303 - 306
  • [8] Hormone replacement therapy and cardio-vascular disease
    Lesiak, Maciej
    Mariola, Ropacka-Lesiak
    Podkowa, Natalia
    GINEKOLOGIA POLSKA, 2016, 87 (01) : 59 - 64
  • [9] THE BENEFITS AND RISKS OF HORMONE REPLACEMENT THERAPY - AN EPIDEMIOLOGIC OVERVIEW
    HARLAP, S
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1992, 166 (06) : 1986 - 1992
  • [10] Hormone Replacement Therapy After Breast Cancer It Is Time
    Bluming, Avrum Zvi
    CANCER JOURNAL, 2022, 28 (03) : 183 - 190